Fluoroquinolone Prophylaxis Selects for Meropenem-nonsusceptible Pseudomonas aeruginosa in Patients With Hematologic Malignancies and Hematopoietic Cell Transplant Recipients-Reference-Cited by-同舟云学术

Fluoroquinolone Prophylaxis Selects for Meropenem-nonsusceptible Pseudomonas aeruginosa in Patients With Hematologic Malignancies and Hematopoietic Cell Transplant Recipients

Published:2018-09-26 Issue:12 Volume:68 Page:2045-2052
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:

Author:

Hakki Morgan¹,Humphries Romney M²,Hemarajata Peera³,Tallman Gregory B⁴,Shields Ryan K⁵,Mettus Roberta T⁵,Doi Yohei⁵⁶,Lewis James S⁷

Affiliation:

1. Division of Infectious Diseases, Oregon Health and Science University, Portland

2. Accelerate Diagnostics, Tucson, Arizona

3. Los Angeles County Department of Public Health, California

4. Department of Pharmacy Practice, Oregon State University/Oregon Health and Science University College of Pharmacy, Portland

5. Division of Infectious Diseases, Center for Innovative Antimicrobial Therapy, University of Pittsburgh School of Medicine, Pennsylvania

6. Departments of Microbiology and Infectious Diseases, Fujita Health University School of Medicine, Toyoake, Aichi, Japan

7. Department of Pharmacy Services, Oregon Health and Science University, Portland

Funder

National Institutes of Health

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/68/12/2045/28739211/ciy825.pdf

Reference35 articles.

1. Multidrug-resistant Enterobacteriaceae, Pseudomonas aeruginosa, and vancomycin-resistant Enterococcus: three major threats to hematopoietic stem cell transplant recipients;Satlin;Transpl Infect Dis,2017

2. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America;Freifeld;Clin Infect Dis,2011

3. Fluoroquinolones, antimicrobial resistance and neutropenic cancer patients;Bow;Curr Opin Infect Dis,2011

4. Of Pseudomonas, porins, pumps and carbapenems;Livermore;J Antimicrob Chemother,2001

5. Development of quinolone-imipenem cross resistance in Pseudomonas aeruginosa during exposure to ciprofloxacin;Rådberg;Antimicrob Agents Chemother,1990

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patterns of fluoroquinolone utilization and resistance in a tertiary care hospital: a retrospective cross-sectional analysis study from a developing country;BMC Infectious Diseases;2024-08-23

2. Clinical and Microbiological Characteristics of Febrile Neutropenia During Induction Chemotherapy in Adults With Acute Leukemia;Cancer Reports;2024-08

3. Evaluation of antimicrobial selective pressure using the multicenter semiautomatic surveillance system Japan surveillance for infection prevention and healthcare epidemiology;Journal of Infection and Public Health;2024-08

4. Fluoroquinolone Prophylaxis in Children With Cancer: A Pro/Con Discussion;Journal of the Pediatric Infectious Diseases Society;2024-07-29

5. Phenotypic and molecular characterization of extended spectrum- and metallo- beta lactamase producing Pseudomonas aeruginosa clinical isolates from Egypt;Infection;2024-06-02